KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dynavax Technologies (DVAX) Asset Writedowns and Impairment: 2021-2025

  • Dynavax Technologies' Asset Writedowns and Impairment was N/A to -$338,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $6.8 million, marking a year-over-year change of. This contributed to the annual value of $3.1 million for FY2024, which is N/A change from last year.
  • Dynavax Technologies' Asset Writedowns and Impairment amounted to -$338,000 in Q3 2025, which was down 108.50% from $4.0 million recorded in Q1 2025.
  • In the past 5 years, Dynavax Technologies' Asset Writedowns and Impairment registered a high of $19.8 million during Q4 2022, and its lowest value of -$338,000 during Q3 2025.
  • For the 2-year period, Dynavax Technologies' Asset Writedowns and Impairment averaged around $1.7 million, with its median value being $1.6 million (2024).
  • Data for Dynavax Technologies' Asset Writedowns and Impairment shows a peak YoY skyrocketed of 665.19% (in 2022) over the last 5 years.
  • Quarterly analysis of 4 years shows Dynavax Technologies' Asset Writedowns and Impairment stood at $2.6 million in 2021, then surged by 665.19% to $19.8 million in 2022, then reached $1.8 million in 2024, then soared by 205.85% to -$338,000 in 2025.
  • Its Asset Writedowns and Impairment stands at -$338,000 for Q3 2025, versus $4.0 million for Q1 2025 and $1.8 million for Q4 2024.